Medvi vs Sprout Health

Choose Medvi if: You exclusively prioritize absolute lowest monthly fees ($197-247/month) for GLP-1 medication access saving $360/year compared to Sprout, accept minimal physician engagement and bare-bones support infrastructure, can self-manage nutrition and lifestyle modifications independently without resources or coaching, and prioritize cost savings over any quality improvements or ancillary services.

Choose Sprout if: You seek value-tier option ($227-277/month) balancing affordability with modest quality improvements, prefer slightly better physician consultations and medical responsiveness over ultra-streamlined approval model, value basic educational resources and customer support over complete absence of guidance, accept higher-quality compounding pharmacy sourcing justifying $30 monthly premium, or want marginal service enhancements while maintaining budget-consciousness.

Bottom line: Medvi and Sprout represent ultra-budget and value-tier GLP-1 weight loss platforms with minimal differentiation—both provide compound semaglutide at affordable pricing with limited support infrastructure. Medvi excels as absolute lowest-cost option ($2,364-2,964/year) through bare-bones operational model. Sprout offers marginal improvements ($2,724-3,324/year) in consultation quality, educational resources, and compounding pharmacy standards for $360 annual premium. The $30/month difference delivers incremental rather than transformative enhancements. Patients seeking complete behavioral support, nutrition coaching, or sophisticated medical management should consider premium platforms (Eden, Ro Body) despite 30-50% higher costs. Between these budget options, extreme cost-sensitivity favors Medvi; modest quality preference justifies Sprout small premium.